SAN FRANCISCO (MarketWatch) -- Nastech Pharmaceutical Co. said Friday it has submitted a response to the Food and Drug Administration's office of generic drugs regarding the potential for ...
September 23, 2011 (San Diego, California) — Oral recombinant salmon calcitonin tablets are more effective at improving lumbar spine bone mineral density (BMD) after 48 weeks than placebo or a nasal ...
(Reuters) - Staff reviewers for the U.S. Food and Drug Administration said that a potential increased risk of cancer with drugs containing calcitonin salmon appears plausible. In briefing documents ...
—Data Presented at ASBMR 2011 Annual Meeting Show Tarsa's Oral Calcitonin Tablet OSTORA™ Achieved Positive Results on Efficacy Endpoints— The ORACAL study was a Phase III multinational, randomized, ...
Staff reviewers for the U.S. Food and Drug Administration said that a potential increased risk of cancer with drugs containing calcitonin salmon appears plausible. Subscribe to read this story ad-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results